Hjem › KOL › Alabama › Birmingham
KOL kliniske forsøg i Birmingham, AL
17 studier for KOL søger deltagere på steder i og omkring Birmingham (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
RekruttererFase 4
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RekruttererFase 2
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2/3
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RekruttererFase 3
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
RekruttererObservationsstudie
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
RekruttererFase 3
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Rekrutterer
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Rekrutterer
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Rekrutterer
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
RekruttererObservationsstudie
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
RekruttererFase 4
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Rekrutterer
- UAB School of Medicine/Lung Health Center, Birmingham
KOL forsøg i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Boston, MA17 studier
- Houston, TX15 studier
- Orlando, FL15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
- Detroit, MI9 studier
Andre studier i Birmingham
- Kræft (alle typer)30 studier
- Brystkræft24 studier
- Overvægt23 studier
- Ægstockræft23 studier
- Ikke-småcellet lungecancer22 studier
- Akut myeloid leukæmi21 studier
- Multipelt myelom18 studier
- Kardiovaskulær sygdom17 studier
- Overvægt16 studier
- Livmoderslimhindekræft16 studier
- Type 2-diabetes16 studier
- Cystisk fibrose16 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.